Ticker Details
Nurix Therapeutics, Inc.
IPO Date:	July 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.62B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.67 | 3.49%
Avg Daily Range (30 D):	$0.47 | 2.69%
Avg Daily Range (90 D):	$0.46 | 2.99%

Institutional Daily Volume
Avg Daily Volume:	.51M
Avg Daily Volume (30 D):	.88M
Avg Daily Volume (90 D):	1.26M

Trade Size
Avg Trade Size (Sh.):	72
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	1,933
Avg Institutional Trade:	$2.05M
Avg Institutional Trade (30 D):	$2.56M
Avg Institutional Trade (90 D):	$2.44M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.98M
Avg Closing Trade (30 D):	$2.69M
Avg Closing Trade (90 D):	$3.66M
Avg Closing Volume:	115.61K

News

Feb 22, 2026 @ 6:12 PM Nurix Stock Is Down 6% This Past Year, but One Bio... Source: Jonathan Ponciano

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Dec 6, 2025 @ 2:30 PM Nurix Therapeutics Presents New Data Demonstrating... Source: Nurix Therapeutics

Dec 1, 2025 @ 12:00 PM Nurix Therapeutics Announces Webcast to Review New... Source: Nurix Therapeutics

Nov 3, 2025 @ 2:00 PM Nurix Therapeutics Announces Presentations at the ... Source: Nurix Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.05	$-.83	$-3.05
Diluted EPS	$-3.05	$-.83	$-3.05
Revenue	$83.98M	$13.58M	$83.98M
Gross Profit
Net Income / Loss	$-264.46M	$-78.22M	$-264.46M
Operating Income / Loss	$-285.67M	$-83.1M	$-285.67M
Cost of Revenue
Net Cash Flow	$137.03M	$168.52M	$137.03M
PE Ratio